Form 144 BeiGene, Ltd. Filed by: HHLR ADVISORS, LTD.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Morgan Stanley Assumes BeiGene, Ltd. (BGNE) at Overweight
December 3, 2024 8:34 AM ESTMorgan Stanley analyst Sean Laaman assumes coverage on BeiGene, Ltd. (NASDAQ: BGNE) with a Overweight rating and a price target of $300.00.
The analyst comments "Superior safety and efficacy of BGNE's 2nd gen BTKi, Brukinsa, continues to drive its market share growth. Brukinsa's developing... More
